Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease

ClinicalTrials.gov ID: NCT00594386

Public ClinicalTrials.gov record NCT00594386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension to the Double-Blind SP650 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Advanced-Stage Idiopathic Parkinson's Disease.

Study identification

NCT ID
NCT00594386
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
UCB Pharma
Industry
Enrollment
258 participants

Conditions and interventions

Interventions

  • Rotigotine Drug

Drug

Eligibility (public fields only)

Age range
31 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2002
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Oct 1, 2014

2002 – 2008

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Not listed Huntsville Alabama
Not listed Peoria Arizona
Not listed Phoenix Arizona
Not listed Tucson Arizona
Not listed Hot Springs Arkansas
Not listed Fountain Valley California
Not listed Fresno California
Not listed Irvine California
Not listed Los Angeles California
Not listed Danbury Connecticut
Not listed Fairfield Connecticut
Not listed New Haven Connecticut
Not listed Miami Florida
Not listed Pompano Beach Florida
Not listed St. Petersburg Florida
Not listed Sunrise Florida
Not listed Atlanta Georgia
Not listed Hoffman Estates Illinois
Not listed Fort Wayne Indiana
Not listed Kansas City Kansas
Not listed Lexington Kentucky
Not listed Boston Massachusetts
Not listed Southfield Michigan
Not listed Minneapolis Minnesota
Not listed Henderson Nevada
Not listed Albany New York
Not listed Forest Hills New York
Not listed Louisville New York
Not listed Asheville North Carolina
Not listed Raleigh North Carolina
Not listed Toledo Ohio
Not listed Upland Pennsylvania
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Richmond Virginia
Not listed Roanoke Virginia
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00594386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00594386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →